Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
TIMOLOL MALEATE
Merck Sharp & Dohme Ireland (Human Health) Limited
TIMOLOL MALEATE
0.25 %w/v
Eye Drops Solution
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
TRACER NO. 0950-IRL-2013-007067 April 2013 1 PROPOSED PACKAGE LEAFLET: INFORMATION FOR THE USER TIMOPTOL ® UNIT DOSE 0.25% W/V EYE DROPS SOLUTION TIMOPTOL ® UNIT DOSE 0.5% W/V EYE DROPS SOLUTION TIMOLOL (AS MALEATE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Timoptol Unit Dose is and what it is used for 2. Before you use Timoptol Unit Dose 3. How to use Timoptol Unit Dose 4. Possible side effects 5. How to store Timoptol Unit Dose 6. Further information 1. WHAT TIMOPTOL UNIT DOSE IS AND WHAT IT IS USED FOR Timoptol Unit Dose contains a substance called timolol which belongs to a group of medicines called beta-blockers. Timolol lowers the pressure in your eye(s). It is used to treat glaucoma, when the pressure in the eye is raised. 2. BEFORE YOU USE TIMOPTOL UNIT DOSE DO NOT USE TIMOPTOL UNIT DOSE IF: • you are allergic (hypersensitive) to timolol maleate, beta-blockers or any of the other ingredients of Timoptol Unit Dose (see section 6 for Further Information) • you have now or have had in the past respiratory problems, such as asthma, severe chronic obstructive bronchitis (severe lung condition which may cause wheeziness, difficulty breathing and/or long-standing cough). • you have heart probl Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Timoptol Unit Dose 0.25 % w/v Eye Drops Solution. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Timoptol Unit Dose 0.25% w/v Eye Drops Solution contains timolol maleate equivalent to 2.5mg/ml of timolol without preservative. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution. Clear, colourless to light yellow, sterile eye drops. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Timoptol Eye Drops Solution is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra- ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Recommended therapy is one drop 0.25% solution in the affected eye twice a day. When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity If clinical response is not adequate, dosage may be changed to one drop 0.5% solution in each affected eye twice a day. If needed, ‘Timoptol’ may be used with other agent(s) for lowering intra-ocular pressure. The use of two topical beta -adrenergic blocking agents is not recommended (see 4.4 ‘Special warnings and precautions for use’). Intra-ocular pressure should be reassessed approximately four weeks after starting treatment because response to ‘Timoptol’ may take a few weeks to stabilise. Provided that the intra-ocular pressure is maintained at satisfactory levels, many patients can then be placed on once-a- day therapy. _Transfer from other agents_ When Read the complete document